Membrane (phospholipid bilayer, invaginating)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc64a/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc64a/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc649/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc649/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc648/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc648/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc647/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc647/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc646/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc646/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc645/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc645/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc644/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc644/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc643/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc643/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc642/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc642/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc641/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc641/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc640/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc640/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc63f/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc63f/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc63e/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc63e/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc63d/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc63d/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc63c/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc63c/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc63b/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc63b/5e4ea752e3a41d0026ebc639.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5e4ea7a7e3a41d0026ebc63a/5e4ea752e3a41d0026ebc639.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5e4ea7a7e3a41d0026ebc63a/5e4ea752e3a41d0026ebc639.png"}]